ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 71 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2013. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $2,271,000 | +11.4% | 189,259 | 0.0% | 0.02% | +17.6% |
| Q1 2015 | $2,038,000 | +107.5% | 189,259 | -2.3% | 0.02% | +70.0% |
| Q4 2014 | $982,000 | +52.0% | 193,640 | -20.8% | 0.01% | +25.0% |
| Q3 2014 | $646,000 | -34.5% | 244,619 | 0.0% | 0.01% | -33.3% |
| Q2 2014 | $986,000 | -12.0% | 244,619 | 0.0% | 0.01% | -14.3% |
| Q1 2014 | $1,120,000 | +1.5% | 244,619 | -3.8% | 0.01% | -12.5% |
| Q4 2013 | $1,103,000 | +10.1% | 254,199 | 0.0% | 0.02% | +14.3% |
| Q3 2013 | $1,002,000 | +86.9% | 254,199 | 0.0% | 0.01% | +27.3% |
| Q2 2013 | $536,000 | – | 254,199 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
| MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
| MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
| Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
| Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
| A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
| EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
| Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |